Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
10326
PUT
Quaker Houghton
KWR
$2.72B
| $168K | ﹤0.01% |
1,000
-2,000
| -67% | -$338K |
2022 Q4
7 quarters
|
|
10327
PUT
Full Truck Alliance
YMM
$8.64B
| $168K | ﹤0.01% |
18,700
-100
| -0.5% | -$767 |
2022 Q1
10 quarters
|
|
10328
Great Elm Capital Corp
GECC
$70.3M
| $168K | ﹤0.01% |
16,648
-11,171
| -40% | -$115K |
2023 Q3
4 quarters
|
|
10329
CALL
Akebia Therapeutics
AKBA
$226M
| $168K | ﹤0.01% |
127,500
+35,700
| +39% | +$47.7K |
2020 Q1
18 quarters
|
|
10330
PUT
Castle Biosciences
CSTL
$1.03B
| $168K | ﹤0.01% |
5,900
+5,800
| +5,800% | +$148K |
2024 Q2
1 quarter
|
|
|
EVRI
10331
PUT
DELISTED
Everi Holdings
EVRI
| $168K | ﹤0.01% |
12,800
+6,600
| +106% | +$77.8K |
2019 Q3
20 quarters
|
|
10332
PUT
iShares MSCI Australia ETF
EWA
$1.2B
| $168K | ﹤0.01% |
6,200
+1,600
| +35% | +$40.5K |
2014 Q1
42 quarters
|
|
|
SOND
10333
PUT
DELISTED
Sonder
SOND
| $168K | ﹤0.01% |
35,900
+32,200
| +870% | +$142K |
2022 Q2
9 quarters
|
|
10334
CALL
Rockwell Medical
RMTI
$32.3M
| $168K | ﹤0.01% |
4,230
+3,130
| +285% | +$84.2K |
2022 Q4
7 quarters
|
|
10335
Goldgroup Mining
GORO
$539M
| $168K | ﹤0.01% |
120,100
+56,600
| +89% | +$89.3K |
2023 Q3
4 quarters
|
|
10336
CALL
ProShares Ultra Technology
ROM
$1.41B
| $168K | ﹤0.01% |
+2,500
| New | +$162K |
2024 Q3
0 quarters
|
|
10337
CALL
ProShares Ultra Real Estate
URE
$46.9M
| $168K | ﹤0.01% |
2,200
+200
| +10% | +$13.6K |
2022 Q4
7 quarters
|
|
10338
PUT
SunCoke Energy
SXC
$828M
| $168K | ﹤0.01% |
19,300
+3,700
| +24% | +$34.3K |
2022 Q4
7 quarters
|
|
10339
PUT
Carriage Services
CSV
$536M
| $167K | ﹤0.01% |
5,100
+1,200
| +31% | +$37.1K |
2022 Q3
8 quarters
|
|
10340
PUT
Polestar Automotive Holding UK
PSNY
$872M
| $167K | ﹤0.01% |
3,243
+2,766
| +580% | +$89.4K |
2024 Q1
2 quarters
|
|
|
OBE
10341
CALL
Obsidian Energy
OBE
$741M
| $167K | ﹤0.01% |
30,200
-20,100
| -40% | -$135K |
2022 Q2
9 quarters
|
|
10342
CALL
YieldMax AMD Option Income Strategy ETF
AMDY
$459M
| $167K | ﹤0.01% |
2,260
+500
| +28% | +$36.9K |
2024 Q2
1 quarter
|
|
|
NXRT
10343
CALL
NexPoint Residential Trust
NXRT
$502M
| $167K | ﹤0.01% |
3,800
-30,400
| -89% | -$1.33M |
2021 Q4
11 quarters
|
|
10344
PUT
VistaGen Therapeutics
VTGN
$10.9M
| $167K | ﹤0.01% |
55,500
+26,700
| +93% | +$91.1K |
2023 Q3
4 quarters
|
|
10345
CALL
Douglas Emmett
DEI
$1.66B
| $167K | ﹤0.01% |
9,500
-96,200
| -91% | -$1.49M |
2022 Q4
7 quarters
|
|
|
PTVE
10346
PUT
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $167K | ﹤0.01% |
14,500
+4,600
| +46% | +$52.8K |
2022 Q4
7 quarters
|
|
|
TURN
10347
CALL
DELISTED
180 Degree Capital
TURN
| $167K | ﹤0.01% |
49,500
-15,900
| -24% | -$54.8K |
2018 Q2
25 quarters
|
|
10348
CALL
Pacific Biosciences
PACB
$715M
| $167K | ﹤0.01% |
98,100
-49,600
| -34% | -$81.5K |
2020 Q3
16 quarters
|
|
10349
Trevi Therapeutics
TRVI
$1.83B
| $167K | ﹤0.01% |
+49,881
| New | +$148K |
2024 Q3
0 quarters
|
|
10350
Perma-Fix Environmental Services
PESI
$300M
| $166K | ﹤0.01% |
13,556
+7,646
| +129% | +$81.8K |
2022 Q4
7 quarters
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.